Tynor Revives Stake Sale Plan With ₹4,000 Crore Valuation

Promoters and Lighthouse Funds Looking to Sell About 60% in Orthopaedic Product Maker

- Priyamvada C & Sneha Shah

Tynor Orthotics, the Mohali-based manufacturer of fracture aids and body braces, has reopened stake sale talks that could value the company at ₹3,500-4,000 crore, with investor Lighthouse Funds and the promoters set to offload a total of about 60% of their holding, two people familiar with the matter said.

At this proposed valuation, Tynor would be valued at about seven times its projected FY26 revenue of ₹600 crore.

The company, which manufactures and exports more than 150 orthopaedic and mobility aids to over 60 countries, now plans to set up a new manufacturing facility to expand its mobility portfolio.

The process has attracted private equity funds and large family offices, highlighting continued investor appetite for India's fast-growing medical devices sector.

"It has reappointed O3 Capital to help with the mandate after the talks with Temasek for a significant minority stake were put on hold last year," one of the people cited above said on the condition of anonymity.